Insider · SEC Form 4 filer
Mark Murray
Past buys: 1 of 4 beat
Companies
Where they file as an insider
Celanese (CE) SVP - Acetyls Latest filing Aug 11, 2026
Track record
Did their buys beat the typical stock?
Open-market buys5
Quarters checked 6 months later4
Beat the typical stock 1 of 4
Quarters too new to check1
1 of 4 checked quarters beat the typical stock. A past record is data, not a forecast.
Celanese (CE) Bought Aug 11, 2026 · $98K · 2,153 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Celanese (CE) Bought Aug 14, 2025 · $84.4K · 2,017 shares Beat typical Sep 30, 2025 $42.08 → Mar 31, 2026 $65.77 · +56.3% (typical stock −3.4%)
Celanese (CE) Bought May 23, 2025 · $77.2K · 1,479 shares Behind typical Jun 30, 2025 $55.33 → Dec 31, 2025 $42.28 · −23.6% (typical stock +2.1%)
Celanese (CE) Bought Mar 7, 2025 · $128K · 2,353 shares Behind typical Mar 31, 2025 $56.77 → Sep 30, 2025 $42.08 · −25.9% (typical stock +7.3%)
Celanese (CE) Bought Mar 8, 2024 · $93.4K · 597 shares Behind typical Mar 31, 2024 $171.86 → Sep 30, 2024 $135.96 · −20.9% (typical stock +3.2%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.